Christine Ann Denny

Title: Christine Ann Denny: Innovator in Prophylactic Treatments for Stress-Induced Disorders

Introduction

Christine Ann Denny is a notable inventor based in Ho-Ho-Kus, New Jersey. She has made significant contributions to the field of mental health through her innovative research and patents. With a total of five patents to her name, Denny is recognized for her work on biomarkers and pharmacological treatments aimed at addressing stress-induced affective disorders.

Latest Patents

Denny's latest patents include groundbreaking methods for assessing the efficacy of prophylactic treatments against stress-induced affective disorders. One of her notable inventions focuses on biomarkers that can indicate the effectiveness of these treatments. Additionally, she has developed pharmacological prophylactics specifically targeting stress-induced affective disorders in females. Her methods involve administering effective amounts of (R,S)-ketamine or (2R,6R)-hydroxynorketamine to enhance stress resilience in subjects prior to exposure to stressors.

Career Highlights

Throughout her career, Christine Ann Denny has worked with prestigious institutions such as Columbia University and the Research Foundation for Mental Hygiene, Inc. Her research has contributed to a deeper understanding of mental health and the development of effective treatments for stress-related conditions.

Collaborations

Denny has collaborated with esteemed colleagues, including Josephine Cecelia McGowan and Michael Andrew Kiebish. These partnerships have furthered her research and expanded the impact of her innovations in the field.

Conclusion

Christine Ann Denny's work exemplifies the intersection of innovation and mental health. Her patents and research continue to pave the way for advancements in the treatment of stress-induced disorders.